NASDAQ:BLUE - bluebird bio Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $137.03 +2.74 (+2.04 %) (As of 02/15/2019 04:00 PM ET)Previous Close$137.03Today's Range$133.90 - $137.2252-Week Range$87.49 - $236.17Volume453,926 shsAverage Volume540,545 shsMarket Capitalization$7.49 billionP/E Ratio-17.77Dividend YieldN/ABeta2.62 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings bluebird bio (NASDAQ:BLUE) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.23 Wall Street analysts have issued ratings and price targets for bluebird bio in the last 12 months. Their average twelve-month price target is $186.7059, suggesting that the stock has a possible upside of 36.25%. The high price target for BLUE is $250.00 and the low price target for BLUE is $120.00. There are currently 1 sell rating, 7 hold ratings, 14 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.652.652.602.50Ratings Breakdown: 1 Sell Rating(s)7 Hold Rating(s)14 Buy Rating(s)1 Strong Buy Rating(s)1 Sell Rating(s)7 Hold Rating(s)14 Buy Rating(s)1 Strong Buy Rating(s)1 Sell Rating(s)8 Hold Rating(s)16 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)8 Hold Rating(s)14 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $186.7059$191.9412$206.7895$212.05Price Target Upside: 36.25% upside66.50% upside71.92% upside35.54% upsidebluebird bio (NASDAQ:BLUE) Consensus Price Target History bluebird bio (NASDAQ:BLUE) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails1/23/2019Canaccord GenuityReiterated RatingBuy ➝ Buy$250.00 ➝ $161.00High1/11/2019OppenheimerReiterated RatingHoldLow1/10/2019JPMorgan Chase & Co.Reiterated RatingBuyHigh12/19/2018Raymond JamesInitiated CoverageStrong-Buy ➝ Strong-Buy$165.00High12/9/2018CowenReiterated RatingBuyLow12/6/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$240.00 ➝ $120.00Medium12/4/2018William BlairReiterated RatingBuyLow12/3/2018Janney Montgomery ScottSet Price TargetOutperform ➝ Buy$170.00High12/3/2018Maxim GroupReiterated RatingHoldHigh12/3/2018Cantor FitzgeraldReiterated RatingHold$134.00High11/27/2018Leerink SwannInitiated CoverageOutperform$145.00 ➝ $145.00Low11/14/2018Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$155.00High11/5/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$186.00 ➝ $185.00Low11/5/2018WedbushLower Price TargetOutperform ➝ Outperform$204.00 ➝ $166.00Medium9/21/2018Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyMedium9/17/2018GuggenheimInitiated CoverageNeutralMedium8/3/2018SunTrust BanksReiterated RatingBuy$223.00High8/3/2018BMO Capital MarketsReiterated RatingBuy$208.00High7/12/2018GabelliInitiated CoverageBuy$239.00Low6/19/2018Evercore ISIUpgradeIn-Line ➝ Outperform$175.00 ➝ $230.00Low5/3/2018BTIG ResearchReiterated RatingBuyHigh3/16/2018UBS GroupInitiated CoverageSellHigh2/22/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$185.00 ➝ $218.00Medium12/21/2017CIBCInitiated CoverageMarket Perform ➝ Market PerformHigh12/13/2017BarclaysReiterated RatingOverweight ➝ Overweight$162.00 ➝ $209.00High12/12/2017Wells Fargo & CoReiterated RatingOutperform$190.00 ➝ $242.00High12/11/2017Jefferies Financial GroupUpgradeHold ➝ Buy$130.00 ➝ $211.00High6/16/2017Standpoint ResearchReiterated RatingBuy ➝ Reduce$110.00Low2/23/2017Roth CapitalSet Price TargetHold$71.00N/A(Data available from 2/16/2017 forward) This page was last updated on 2/16/2019 by MarketBeat.com StaffFeatured Article: What are the Different Types of Leveraged Buyouts?